SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-11-099324
Filing Date
2011-04-15
Accepted
2011-04-15 15:08:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14D-9C dsc14d9c.htm SC14D9C 7599
2 LIST OF FREQUENTLY ASKED QUESTIONS dex99a.htm EX-99.A 32483
3 GRAPHIC g174856g06o56.jpg GRAPHIC 4509
4 GRAPHIC g174856g22p27.jpg GRAPHIC 4729
  Complete submission text file 0001193125-11-099324.txt   54672
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filed by) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Subject) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-60379 | Film No.: 11762407
SIC: 2834 Pharmaceutical Preparations